{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:39:21Z","timestamp":1769762361889,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T00:00:00Z","timestamp":1169683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T00:00:00Z","timestamp":1169683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s11060-006-9326-7","type":"journal-article","created":{"date-parts":[[2007,1,24]],"date-time":"2007-01-24T14:16:01Z","timestamp":1169648161000},"page":"295-302","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Successful treatment of cancer-associated retinopathy with alemtuzumab"],"prefix":"10.1007","volume":"83","author":[{"given":"Ladan","family":"Espandar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Thirkill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda A.","family":"Lubecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bita","family":"Esmaeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,1,25]]},"reference":[{"key":"9326_CR1","first-page":"2497","volume-title":"Walsh & Hoyts clinical neuro-ophthalmology","author":"DM Jacobson","year":"1998","unstructured":"Jacobson DM (1998) Paraneoplastic diseases of neuro-ophthalmologic interest. In: Miller NR, Newman N (eds) Walsh & Hoyts clinical neuro-ophthalmology, 5th edn. Williams and Wilkins, Baltimore, pp 2497\u20132551"},{"key":"9326_CR2","first-page":"2626","volume":"34","author":"G Adamus","year":"1993","unstructured":"Adamus G, Guy J, Schmied JL et al (1993) Role of anti-recoverin autoantibodies in cancer-associated retinopathy. Invest Ophthalmol Vis Sci 34:2626\u20132633","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9326_CR3","first-page":"2768","volume":"33","author":"CE Thirkill","year":"1992","unstructured":"Thirkill CE, Tait RC, Tyler NK et al (1992) The cancer-associated retinopathy antigen is a recoverin-like protein. Invest Ophthalmol Vis Sci 33:2768\u20132772","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9326_CR4","first-page":"137","volume":"12","author":"S Malik","year":"1992","unstructured":"Malik S, Furlan AJ, Sweeney PJ, Kosmorsky GS, Wong M (1992) Optic neuropathy: a rare paraneoplastic syndrome. J Clin Neuroophthalmol 12:137\u2013141","journal-title":"J Clin Neuroophthalmol"},{"key":"9326_CR5","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S0002-9394(98)00212-8","volume":"126","author":"JL Keltner","year":"1998","unstructured":"Keltner JL, Thirkill CE (1998) Cancer-associated retinopathy vs recoverin-associated retinopathy. Am J Ophthalmol 126:296\u2013302","journal-title":"Am J Ophthalmol"},{"key":"9326_CR6","first-page":"178","volume":"18","author":"JE Luiz","year":"1998","unstructured":"Luiz JE, Lee AG, Keltner JL, Thirkill CE, Lai EC (1998) Paraneoplastic optic neuropathy and autoantibody production in small-cell carcinoma of the lung. J Neuroophthalmol 18:178\u2013181","journal-title":"J Neuroophthalmol"},{"key":"9326_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/archneur.55.3.405","volume":"55","author":"V de la Sayette","year":"1998","unstructured":"de la Sayette V, Bertran F, Honnorat J, Schaeffer S, Iglesias S, Defer G (1998) Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies: clinical response to excision of the primary tumor. Arch Neurol 55:405\u2013408","journal-title":"Arch Neurol"},{"key":"9326_CR8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00041327-200109000-00002","volume":"21","author":"MR Thambisetty","year":"2001","unstructured":"Thambisetty MR, Scherzer CR, Yu Z, Lennon VA, Newman NJ (2001) Paraneoplastic optic neuropathy and cerebellar ataxia with small cell carcinoma of the lung. J Neuroophthalmol 21:164\u2013167","journal-title":"J Neuroophthalmol"},{"key":"9326_CR9","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/S0140-6736(04)16005-4","volume":"363","author":"AC Browning","year":"2004","unstructured":"Browning AC, Amoaku WM, Vernon SA et al (2004) Cachexia and poor night vision. Lancet 363:1305","journal-title":"Lancet"},{"key":"9326_CR10","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJM198912073212307","volume":"321","author":"Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic nerve, and cancer cells","year":"1989","unstructured":"Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic nerve, and cancer cells. (1989) N Engl J Med 321:1589\u20131594","journal-title":"N Engl J Med"},{"key":"9326_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1600-0609.2004.00280.x","volume":"73","author":"T Hohwy","year":"2004","unstructured":"Hohwy T, Bang K, Steiniche T, Peterslund NA, d_Amore F (2004) Alemtuzumab-induced remission of both severe paraneoplastic pemphigus and leukaemic bone marrow infiltration in a case of treatment-resistant B-cell chronic lymphocytic leukaemia. Eur J Haematol 73:206\u2013209","journal-title":"Eur J Haematol"},{"key":"9326_CR12","unstructured":"Full prescribing information (PI) for Campath\u00ae. www.campath.com"},{"key":"9326_CR13","first-page":"322","volume":"91","author":"J Golay","year":"2006","unstructured":"Golay J, Cortiana C, Manganini M et al (2006) The sensitivity of acute lymphoblastic leukemia cells carrying the t(12;21) translocation to campath-1H-mediated cell lysis. Haematologica 91:322\u2013330","journal-title":"Haematologica"},{"key":"9326_CR14","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1002\/cncr.21405","volume":"104","author":"F Ravandi","year":"2005","unstructured":"Ravandi F, Kantarjian H, Jones D, Dearden C, Keating M, O\u2019Brien S (2005) Mature T-cell leukemias. Cancer 104:1808\u20131818","journal-title":"Cancer"},{"key":"9326_CR15","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.bbmt.2005.05.010","volume":"11","author":"A Busca","year":"2005","unstructured":"Busca A, Locatelli F, Lovisone E et al (2005) Treatment of severe refractory acute graft-versus-host disease of the gastrointestinal tract with campath-1H. Biol Blood Marrow Transplant 11:734\u2013736","journal-title":"Biol Blood Marrow Transplant"},{"key":"9326_CR16","doi-asserted-by":"crossref","unstructured":"Wertheim MS, Ross AH, Tole DM. The use of Campath in severe peripheral ulcerative keratitis associated with Wegener\u2019s granulomatosis. Eye Advance. Online publication, 7 April 2006; doi:10.1038\/sj.eye.6702330","DOI":"10.1038\/sj.eye.6702330"},{"key":"9326_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00415-005-0934-5","volume":"253","author":"AJ Coles","year":"2006","unstructured":"Coles AJ, Cox A, Le Page E et al (2006) The window of therapeutic opportunity in multiple sclerosis: Evidence from monoclonal antibody therapy. J Neurol 253:98\u2013108","journal-title":"J Neurol"},{"key":"9326_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bbmt.2005.09.010","volume":"12","author":"Y Chalandon","year":"2006","unstructured":"Chalandon Y, Roosnek E, Mermillod B, Waelchli L, Helg C, Chapuis B (2006) Can only partial T-cell depletion of the graft before hematopoietic stem cell transplantation mitigate graft-versus-host disease while preserving a graft-versus-leukemia reaction? A prospective phase II study. Biol Blood Marrow Transplant 12:102\u2013110","journal-title":"Biol Blood Marrow Transplant"},{"key":"9326_CR19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.1992.01080130050025","volume":"110","author":"JL Keltner","year":"1992","unstructured":"Keltner JL, Thirkill CE, Tyler NK et al (1992) Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol 110:48\u201353","journal-title":"Arch Ophthalmol"},{"key":"9326_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/ana.410280208","volume":"28","author":"DM Jacobson","year":"1990","unstructured":"Jacobson DM, Thirkill CE, Tipping SJ (1990) A clinical triad to diagnose paraneoplastic retinopathy. Ann Neurol 28:162\u2013167","journal-title":"Ann Neurol"},{"key":"9326_CR21","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2169\/internalmedicine.38.597","volume":"38","author":"K Kashiwabara","year":"1999","unstructured":"Kashiwabara K, Nakamura H, Kishi K et al (1999) Cancer-associated retinopathy during treatment for small-cell lung carcinoma. Intern Med 38:597\u2013601","journal-title":"Intern Med"},{"key":"9326_CR22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/archopht.1987.01060030092033","volume":"105","author":"CE Thirkill","year":"1987","unstructured":"Thirkill CE, Roth AM, Keltner JL (1987) Cancer-associated retinopathy. Arch Ophthalmol 105:372\u2013375","journal-title":"Arch Ophthalmol"},{"key":"9326_CR23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.1992.01080130050025","volume":"110","author":"JL Keltner","year":"1992","unstructured":"Keltner JL, Thirkill CE, Tyler NK et al (1992) Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol 110:48\u201353","journal-title":"Arch Ophthalmol"},{"key":"9326_CR24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3341\/kjo.1999.13.1.43","volume":"13","author":"YH Yoon","year":"1999","unstructured":"Yoon YH, Cho EH, Sohn J, Thirkill CE (1999) An unusual type of cancer-associated retinopathy in a patient with ovarian cancer. Korean J Ophthalmol 13:43\u201348","journal-title":"Korean J Ophthalmol"},{"key":"9326_CR25","first-page":"77","volume":"17","author":"MA Murphy","year":"1996","unstructured":"Murphy MA, Thirkill CE, Hart WM (1996) Paraneoplastic retinopathy: a novel autoantibody reaction associated with small cell lung carcinoma. J Neuroophthalmol 17:77\u201383","journal-title":"J Neuroophthalmol"},{"key":"9326_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0169-5002(98)00062-2","volume":"22","author":"R Salgia","year":"1998","unstructured":"Salgia R, Hedges TR, Rizk M et al (1998) Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma. Lung Cancer 22:149\u2013152","journal-title":"Lung Cancer"},{"key":"9326_CR27","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJM198912073212307","volume":"321","author":"CE Thirkill","year":"1989","unstructured":"Thirkill CE, FitzGerald P, Sergott RC et al (1989) Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. N Engl J Med 321:1589\u20131594","journal-title":"N Engl J Med"},{"key":"9326_CR28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archopht.117.4.471","volume":"117","author":"J Guy","year":"1999","unstructured":"Guy J, Aptsiauri N (1999) Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. Arch Ophthalmol 117:471\u2013477","journal-title":"Arch Ophthalmol"},{"key":"9326_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/PL00012735","volume":"236","author":"H Brink","year":"1997","unstructured":"Brink H, Deutman A, Beex L (1997) Unusual retinal pigment epitheliopathy and choroidopathy in carcinomatosis: a rare case of cancer-associated retinopathy. Graefes Arch Clin Exp Ophthalmol 236:75","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-006-9326-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-006-9326-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-006-9326-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-006-9326-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T20:49:50Z","timestamp":1652734190000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-006-9326-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,25]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["9326"],"URL":"https:\/\/doi.org\/10.1007\/s11060-006-9326-7","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,25]]},"assertion":[{"value":"27 September 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}